Lataa...
Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial
BACKGROUND: Human papillomavirus (HPV) is one of the most significant risk factors for cervical cancer. The HPV vaccine has a very significant impact on the incidence of cervical cancer. The present study aimed to investigate the impact of prophylactic quadrivalent HPV vaccine in the treatment of wo...
Tallennettuna:
| Julkaisussa: | BMC Public Health |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7045378/ https://ncbi.nlm.nih.gov/pubmed/32106837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12889-020-8371-z |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|